Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
51.9 EUR | +4.85% | +12.10% | -6.65% |
06-18 | Borse Frankfurt-News: Many winners and many losers (second-line stocks) | DP |
06-13 | Formycon Starts Clinical Trials of Keytruda Biosimilar Candidate for Skin Cancer Therapy | MT |
- Stock Market
- Equities
- FYB Stock
- FYB Stock
- News Formycon AG
- Other languages